Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP

Abroad (travel likely)Recruiting

Conditions

Substance Use Disorder · Alcohol Use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institute on Drug Abuse, Baltimore, Maryland, United States
Contact: Study coordinator (Lorenzo Leggio, M.D.) · lorenzo.leggio@nih.gov · 240-478-1503
Contact: Study coordinator (Shannon Pfistner) · pfistners@nida.nih.gov · (667) 312-5240

Study leads

Lorenzo Leggio, M.D.
Principal Investigator
National Institute on Drug Abuse (NIDA)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Assessing Habitual, Goal-Directed, and Pavlovian Influences in Alcohol Use Disorder

Alcohol Use Disorder (AUD) · Alcoholism · Substance Use Disorders

Abroad (travel likely)Recruiting

Dresden, Germany

Hepatic Lipid Metabolism-Alcohol Use Disorder

Alcohol Use Disorder

Abroad (travel likely)Recruiting

Bethesda, United States

Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START

Substance Use Disorder (SUD) · Rural Health · Family Resilience

Abroad (travel likely)Recruiting

Columbus, United States

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

Alcohol Use Disorder

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States